For the Inventor, By the Inventor

Enter assignee name

Copenhagen, Denmark

Nuevolution A/s

USPTO Granted Patents = 32

% Expired Patents = 12.5

CIPO Patents = 2

EPO Patents = 20

Trademarks = 2

Forward Citations = 277

Loading Chart...

Loading Chart...

63 inventors (with patents filed for the assignee):

Alex Haahr Gouliaev (27 out of 37 patents)

Thomas Franch (23 out of 26 patents)

Henrik Pedersen (16 out of 50 patents)

4. Anette Holtmann (14 out of 17 patents)

5. Jakob Felding (13 out of 31 patents)

6. Sanne Schrøder Glad (13 out of 14 patents)

7. Eva Kampmann Olsen (12 out of 14 patents)

8. Per-Ola Freskgard (11 out of 13 patents)

9. Christian Klarner Sams (11 out of 20 patents)

10. Mikkel Dybro Lundorf (10 out of 15 patents)

11. Thomas Thisted (9 out of 24 patents)

12. Ian Sarvary (8 out of 8 patents)

13. Luigi Piero Stasi (8 out of 8 patents)

14. Michael Anders Godskesen (8 out of 12 patents)

15. Gitte Nystrup Husemoen (6 out of 7 patents)

Core Competencies:

Bifunctional Complexes

Nuclear Receptors

Chemical Entity Selection

Templated Molecules

Enzymatic Encoding

Heterocyclyl-Substituted Derivatives

Bromodomains

Library Synthesis

Ligational Encoding

Quasirandom Synthesis

32 patents: Sort by Forward Citations

1. 12649918 - BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES (2026-06-09),

2. 12441704 - Compounds active towards nuclear receptors (2025-10-14),

3. 11965209 - Method for obtaining structural information concerning an encoded molecule and method for selecting compounds (2024-04-23),

4. 11780843 - Compounds active towards nuclear receptors (2023-10-10),

5. 11702652 - Enzymatic encoding methods for efficient synthesis of large libraries (2023-07-18),

6. 11685727 - Compounds active towards nuclear receptors (2023-06-27),

7. 11613532 - Compounds active towards nuclear receptors (2023-03-28),

8. 11447479 - Compounds active towards nuclear receptors (2022-09-20),

9. 11254681 - Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases (2022-02-22),

10. 11225655 - Bi-functional complexes and methods for making and using such complexes (2022-01-18),

11. 11118215 - Method for obtaining structural information concerning an encoded molecule and method for selecting compounds (2021-09-14),

12. 11001835 - Method for the synthesis of a bifunctional complex (2021-05-11),

13. 10752640 - Compounds active towards bromodomains (2020-08-25),

14. 10731151 - Method for synthesising templated molecules (2020-08-04),

15. 10689383 - Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases (2020-06-23),

Company Overview

Nuevolution A/S is a biotechnology company based in Copenhagen, Denmark, specializing in the discovery and development of novel small molecule therapeutics. The organization employs its proprietary drug discovery platform to identify and optimize compounds targeting various diseases, particularly in the fields of oncology and autoimmune disorders. With a focus on innovative approaches, Nuevolution aims to address unmet medical needs through advanced research and development in the life sciences sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

32 Patents

#14 in Copenhagen

#99 in Denmark

#20,671 in the World

Copenhagen, Denmark

Nuevolution A/s

Forward Citations = 277

63 inventors:

Alex Haahr Gouliaev (27 out of 37 patents)

Thomas Franch (23 out of 26 patents)

Henrik Pedersen (16 out of 50 patents)

4. Anette Holtmann (14 out of 17 patents)

5. Jakob Felding (13 out of 31 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nuevolution A/s. Retrieved from https://idiyas.com/company/nuevolution-a-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…